Alexandre Esteves Medina

Alexandre Esteves Medina

Auto-generated profile, based on publicly available information

Alexandre Esteves Medina

Division of Neonatology, Department of Pediatrics, University of Maryland School of Medicine, Baltimore, MD, USA.

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in Cell
Verified
Journal Article
Closed access
SSSandeep K. Singh
Sandeep K. Singh
JSJeff A. Stogsdill
Jeff A. Stogsdill
NPNisha S. Pulimood
Nisha S. Pulimood
HDHayley Dingsdale
Hayley Dingsdale
YKYong Ho Kim
Yong Ho Kim
CECagla Eroglu
Cagla Eroglu

1 March 2013 in Biological Psychiatry
Verified
Journal Article
Closed access
SFSylvia Fitting
Sylvia Fitting
BIBogna M Ignatowska-Jankowska
Bogna M Ignatowska-Jankowska
CBCecilia Bull
Cecilia Bull
RSRobert P. Skoff
Robert P. Skoff
ALAron H. Lichtman
Aron H. Lichtman
KHKurt F. Hauser
Kurt F. Hauser

2 March 2018 in Biopreservation and Biobanking
Verified
Journal Article
Open access
KWKimberly White
Kimberly White
PYPeixin Yang
Peixin Yang
LLLing Li
Ling Li
AFAmna Farshori
Amna Farshori
AMAlexandre E. Medina
Alexandre E. Medina
HZHorst Ronald Zielke
Horst Ronald Zielke
Brain tissue from 1068 donors was analyzed for RNA quality as a function of postmortem interval (PMI) and years in storage. Approximately 83% of the cortical and cerebellar samples had an RNA integrity number (RIN) of 6 or greater, indicating their likely suitability for real-time quantitative polymerase chain reaction research. The average RIN value was independent of the PMI, up to at least 36 hours. The RNA quality for specific donated brains could not be predicted based on the PMI. Individual samples with a low PMI could have a poor RIN value, while a sample with a PMI over 36 hours may have a high RIN value. The RIN values for control brain donors, all of whom died suddenly and unexpectedly, were marginally higher than for individuals with clinical brain disorders. Polymerase chain reaction (PCR) analysis of samples confirmed that RIN values were more critical than PMI for determining suitability of tissue for molecular biological studies and samples should be matched by their RIN values rather than PMI. Importantly, PCR analysis established that tissue stored up to 23 years at −80°C yielded high-quality RNA. These results confirm that postmortem human brain tissue collected by brain and tissue banks over decades can serve as high quality material for the study of human disorders.

21 May 2010 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
AMAlexandre E. Medina
Alexandre E. Medina

1 January 2011 in Frontiers in Neuroscience
Verified
Journal Article
Open access
PDF file
AMAlexandre E. Medina
Alexandre E. Medina
Neuronal plasticity is an essential property of the brain that is impaired in different neurological conditions. Phosphodiesterase type 1 (PDE1) inhibitors can enhance levels of the second messengers cAMP/cGMP leading to the expression of neuronal plasticity-related genes, neurotrophic factors, and neuroprotective molecules. These neuronal plasticity enhancement properties make PDE1 inhibitors good candidates as therapeutic agents in many neurological conditions. However, the lack of specificity of the drugs currently available poses a challenge to the systematic evaluation of the beneficial effect of these agents. The development of more specific drugs may pave the way for the use of PDE1 inhibitors as therapeutic agents in cases of neurodevelopmental conditions such as fetal alcohol spectrum disorders and in degenerative disorders such as Alzheimer's and Parkinson's.

7 March 2011 in The Neuroscientist
Verified
Journal Article
Closed access
PDF file
AMAlexandre E. Medina
Alexandre E. Medina
The ingestion of alcohol during pregnancy can result in a group of neurobehavioral abnormalities collectively known as fetal alcohol spectrum disorders (FASD). During the past decade, studies using animal models indicated that early alcohol exposure can dramatically affect neuronal plasticity, an essential property of the central nervous system responsible for the normal wiring of the brain and involved in processes such as learning and memory. The abnormalities in neuronal plasticity caused by alcohol can explain many of the neurobehavioral deficits observed in FASD. Conversely, improving neuronal plasticity may have important therapeutic benefits. In this review, the author discuss the mechanisms that lead to these abnormalities and comment on recent pharmacological approaches that have been showing promising results in improving neuronal plasticity in FASD.